Rare Disease & Gene Therapy Digest • June 29, 2026 Rare Disease & Gene Therapy Digest June 29, 2026 BridgeBio’s oral infigratinib became the first achondroplasia therapy to… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here